NXF2B
gene geneOn this page
Also known as bA353J17.1
Summary
NXF2B (nuclear RNA export factor 2B, HGNC:23984) is a protein-coding gene on chromosome Xq22.1, encoding Nuclear RNA export factor 2 (Q9GZY0). Involved in the export of mRNA from the nucleus to the cytoplasm.
This gene encodes a member of a family of nuclear RNA export proteins. The encoded protein is associated with the nuclear envelope and aids in the export of mRNAs. There is a closely related paralog of this gene located adjacent on chromosome X and on the opposite strand.
Source: NCBI Gene 728343 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 27 total
- MANE Select transcript:
NM_001099686
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23984 |
| Approved symbol | NXF2B |
| Name | nuclear RNA export factor 2B |
| Location | Xq22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA353J17.1 |
| Ensembl gene | ENSG00000269437 |
| Ensembl biotype | protein_coding |
| Entrez | 728343 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 retained_intron
ENST00000489531, ENST00000602195, ENST00000604395
RefSeq mRNA: 1 — MANE Select: NM_001099686
NM_001099686
CCDS: CCDS43979
Canonical transcript exons
ENST00000602195 — 23 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002976390 | 102369963 | 102370152 |
| ENSE00002979739 | 102369199 | 102369282 |
| ENSE00002989649 | 102368058 | 102368165 |
| ENSE00003000229 | 102365224 | 102365331 |
| ENSE00003058561 | 102368286 | 102368374 |
| ENSE00003084900 | 102365463 | 102365518 |
| ENSE00003091967 | 102369586 | 102369736 |
| ENSE00003096179 | 102368531 | 102368600 |
| ENSE00003105958 | 102363980 | 102364052 |
| ENSE00003115966 | 102364791 | 102364906 |
| ENSE00003122684 | 102368983 | 102369087 |
| ENSE00003135730 | 102379994 | 102380089 |
| ENSE00003140595 | 102367769 | 102367878 |
| ENSE00003144428 | 102365045 | 102365103 |
| ENSE00003146804 | 102364653 | 102364695 |
| ENSE00003159400 | 102368787 | 102368867 |
| ENSE00003183073 | 102366054 | 102366090 |
| ENSE00003208093 | 102365605 | 102365673 |
| ENSE00003543318 | 102360792 | 102360852 |
| ENSE00003723933 | 102363263 | 102363445 |
| ENSE00003822645 | 102438553 | 102438674 |
| ENSE00003978264 | 102360395 | 102360645 |
| ENSE00003978265 | 102439870 | 102440008 |
Expression profiles
Bgee: expression breadth broad, 85 present calls, max score 85.52.
Top tissues by expression
114 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.52 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.93 | gold quality |
| right uterine tube | UBERON:0001302 | 81.07 | gold quality |
| pituitary gland | UBERON:0000007 | 75.16 | gold quality |
| adenohypophysis | UBERON:0002196 | 73.48 | gold quality |
| left testis | UBERON:0004533 | 70.01 | gold quality |
| testis | UBERON:0000473 | 69.63 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 68.23 | gold quality |
| right testis | UBERON:0004534 | 67.55 | gold quality |
| fallopian tube | UBERON:0003889 | 61.32 | gold quality |
| right lung | UBERON:0002167 | 59.47 | gold quality |
| hypothalamus | UBERON:0001898 | 54.79 | gold quality |
| ganglionic eminence | UBERON:0004023 | 54.75 | gold quality |
| left uterine tube | UBERON:0001303 | 53.90 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 52.21 | gold quality |
| islet of Langerhans | UBERON:0000006 | 51.86 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 51.84 | gold quality |
| cerebellum | UBERON:0002037 | 51.80 | gold quality |
| cerebellar cortex | UBERON:0002129 | 51.74 | gold quality |
| nucleus accumbens | UBERON:0001882 | 50.59 | gold quality |
| caudate nucleus | UBERON:0001873 | 48.72 | gold quality |
| brain | UBERON:0000955 | 48.23 | gold quality |
| primary visual cortex | UBERON:0002436 | 48.09 | gold quality |
| temporal lobe | UBERON:0001871 | 47.90 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 47.87 | gold quality |
| amygdala | UBERON:0001876 | 47.86 | gold quality |
| sural nerve | UBERON:0015488 | 47.44 | silver quality |
| fundus of stomach | UBERON:0001160 | 47.03 | gold quality |
| putamen | UBERON:0001874 | 46.31 | gold quality |
| cortical plate | UBERON:0005343 | 45.58 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.23 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
18 targeting NXF2B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-4496 | 99.88 | 68.89 | 2236 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-147B-5P | 99.45 | 70.62 | 2432 |
| HSA-MIR-149-5P | 99.25 | 67.16 | 1315 |
| HSA-MIR-3125 | 99.14 | 68.49 | 2269 |
| HSA-MIR-3916 | 98.99 | 68.04 | 2155 |
| HSA-MIR-6859-5P | 98.99 | 68.07 | 2049 |
| HSA-MIR-4764-5P | 98.88 | 65.53 | 894 |
| HSA-MIR-6794-3P | 98.76 | 66.99 | 894 |
| HSA-MIR-583 | 98.71 | 67.44 | 1791 |
| HSA-MIR-138-5P | 98.43 | 70.49 | 1292 |
| HSA-MIR-4299 | 98.28 | 66.96 | 850 |
| HSA-MIR-4483 | 98.09 | 64.12 | 1642 |
| HSA-MIR-1293 | 96.16 | 64.69 | 916 |
| HSA-MIR-1306-3P | 87.45 | 66.21 | 44 |
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nxf1b | ENSDARG00000055076 |
| danio_rerio | nxf1a | ENSDARG00000086017 |
| mus_musculus | Nxf2 | ENSMUSG00000009941 |
| mus_musculus | Nxf7 | ENSMUSG00000031410 |
| rattus_norvegicus | Nxf2 | ENSRNOG00000011729 |
| rattus_norvegicus | Nxf7 | ENSRNOG00000023256 |
| drosophila_melanogaster | nxf4 | FBGN0051501 |
| caenorhabditis_elegans | WBGENE00003834 | |
| caenorhabditis_elegans | WBGENE00003835 |
Paralogs (3): NXF3 (ENSG00000147206), NXF1 (ENSG00000162231), NXF2 (ENSG00000269405)
Protein
Protein identifiers
Nuclear RNA export factor 2 — Q9GZY0 (reviewed: Q9GZY0)
Alternative names: Cancer/testis antigen 39, TAP-like protein 2
All UniProt accessions (1): Q9GZY0
UniProt curated annotations — full annotation on UniProt →
Function. Involved in the export of mRNA from the nucleus to the cytoplasm.
Subunit / interactions. Interacts with NXT1, NXT2, E1B-AP5, the REF proteins and with nucleoporins, Nup62, Nup153 and Nup214. Interacts with LUZP4.
Subcellular location. Nucleus. Nucleoplasm. Cytoplasm.
Tissue specificity. Expressed almost exclusively in testis. Also expressed in several cancers.
Domain organisation. The NTF2 domain heterodimerizes with NXT1 and NXT2. The formation of NXF1/NXT1 heterodimers is required for NXF2-mediated nuclear mRNA export. The leucine-rich repeats and the NTF2-domain are essential for the export of mRNA from the nucleus. The C-terminal fragment, containing the TAP domain (also called UBA-like domain) and part of the NTF2-like domain, named the NPC-binding domain, mediates direct interactions with nucleoporin-FG-repeats and is necessary and sufficient for localization of NXF2 to the nuclear rim. The RNA-binding domain is a non-canonical RNP-type domain.
Similarity. Belongs to the NXF family.
RefSeq proteins (1): NP_001093156* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001611 | Leu-rich_rpt | Repeat |
| IPR002075 | NTF2_dom | Domain |
| IPR005637 | TAP_C_dom | Domain |
| IPR009060 | UBA-like_sf | Homologous_superfamily |
| IPR012677 | Nucleotide-bd_a/b_plait_sf | Homologous_superfamily |
| IPR015245 | Tap_RNA-bd | Domain |
| IPR018222 | Nuclear_transport_factor_2_euk | Domain |
| IPR030217 | NXF_fam | Family |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
| IPR032710 | NTF2-like_dom_sf | Homologous_superfamily |
| IPR035979 | RBD_domain_sf | Homologous_superfamily |
| IPR057125 | NXF1/2/3/5-like_LRR | Domain |
Pfam: PF03943, PF09162, PF22602, PF24048
UniProt features (12 total): repeat 4, domain 3, mutagenesis site 3, chain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9GZY0-F1 | 76.73 | 0.53 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 34
Mutagenesis-validated functional residues (3):
| Position | Phenotype |
|---|---|
| 599 | suppresses fg-nucleoporin binding. |
| 600 | has no effect on fg-nucleoporin binding. |
| 598 | has no effect on fg-nucleoporin binding. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript |
MSigDB gene sets: 23 (showing top):
GOBP_NUCLEAR_TRANSPORT, REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA, GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT, GOBP_NUCLEAR_EXPORT, GOBP_RNA_LOCALIZATION, REACTOME_METABOLISM_OF_RNA, chrXq22, GOBP_RNA_EXPORT_FROM_NUCLEUS, GOBP_MRNA_EXPORT_FROM_NUCLEUS, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B, GOBP_POLY_A_PLUS_MRNA_EXPORT_FROM_NUCLEUS, GOBP_INTRACELLULAR_TRANSPORT, GOBP_MRNA_TRANSPORT, GOBP_ESTABLISHMENT_OF_RNA_LOCALIZATION, MIR4795_3P
GO Biological Process (4): mRNA export from nucleus (GO:0006406), poly(A)+ mRNA export from nucleus (GO:0016973), RNA transport (GO:0050658), mRNA transport (GO:0051028)
GO Molecular Function (3): RNA binding (GO:0003723), nucleic acid binding (GO:0003676), protein binding (GO:0005515)
GO Cellular Component (5): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytoplasm (GO:0005737), cytosol (GO:0005829), nuclear RNA export factor complex (GO:0042272)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Transport of Mature Transcript to Cytoplasm | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| binding | 2 |
| RNA export from nucleus | 1 |
| gene expression | 1 |
| mRNA transport | 1 |
| mRNA export from nucleus | 1 |
| nucleic acid transport | 1 |
| establishment of RNA localization | 1 |
| RNA transport | 1 |
| nucleic acid binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
| nuclear protein-containing complex | 1 |
Protein interactions and networks
STRING
1038 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NXF2B | NXT1 | Q9UKK6 | 987 |
| NXF2B | NUTF2 | P13662 | 887 |
| NXF2B | NXT2 | Q9NPJ8 | 857 |
| NXF2B | FMR1 | Q06787 | 828 |
| NXF2B | NUP153 | P49790 | 709 |
| NXF2B | NUP62 | P37198 | 701 |
| NXF2B | NUP214 | P35658 | 687 |
| NXF2B | FMR1NB | Q8N0W7 | 641 |
| NXF2B | TNPO2 | O14787 | 638 |
| NXF2B | NUP98 | P52948 | 633 |
| NXF2B | TAF7L | Q5H9L4 | 618 |
| NXF2B | NPAS4 | Q8IUM7 | 599 |
| NXF2B | PIWIL1 | Q96J94 | 592 |
| NXF2B | HNRNPUL1 | Q9BUJ2 | 589 |
| NXF2B | CT45A1 | Q5HYN5 | 570 |
IntAct
18 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NXF2B | NXT2 | psi-mi:“MI:0915”(physical association) | 0.680 |
| NXF2B | NXT1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZC3HC1 | TPR | psi-mi:“MI:0914”(association) | 0.640 |
| KLHL22 | TMEM223 | psi-mi:“MI:0914”(association) | 0.640 |
| NXF2B | HEXB | psi-mi:“MI:0915”(physical association) | 0.560 |
| NXF2B | Nxt1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| NXF2B | MEIOC | psi-mi:“MI:0914”(association) | 0.350 |
| LNX1 | LRFN4 | psi-mi:“MI:0914”(association) | 0.350 |
| NXF5 | LRP6 | psi-mi:“MI:0914”(association) | 0.350 |
| NXT2 | MYO1G | psi-mi:“MI:0914”(association) | 0.350 |
| NXT2 | NXF2B | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (116): LUZP4 (Affinity Capture-Western), NXF2 (Affinity Capture-MS), NXF2 (Affinity Capture-MS), NXF2B (Affinity Capture-MS), C17orf104 (Affinity Capture-MS), DVL2 (Affinity Capture-MS), GLE1 (Affinity Capture-MS), STOX2 (Affinity Capture-MS), NXF2B (Affinity Capture-MS), DVL3 (Affinity Capture-MS), NXF2B (Affinity Capture-MS), ZNF106 (Affinity Capture-MS), FAM120B (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), NXT2 (Affinity Capture-MS)
ESM2 similar proteins: A0A1L1SUL6, A4QJJ7, A4QK16, A6H5F6, A6MM34, A6NH52, A6NMK7, A7M939, A8SEA1, A8W3M5, B0Z4S1, B0Z505, B0Z589, B0Z5H3, B1AR13, B1NWE8, B2LMJ1, O19048, O19137, O95639, P0C7P0, P0DI19, P46292, P60335, P83870, P83871, P98138, Q09G48, Q0G9M1, Q0WMV8, Q15365, Q1KXW1, Q332Y0, Q5E9A3, Q5FVR7, Q5R654, Q63789, Q66KE3, Q68S08, Q6DJP7
Diamond homologs: O35381, O88984, P49911, P58797, Q1RMS5, Q5R752, Q8ILI6, Q92688, Q99JX7, Q9GZY0, Q9H1B4, Q9H4D5, Q9U1H9, Q9UBU9, Q9XVS8, Q3SZC6
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| NXF2 | “form complex” | “NXF2-NXT1 mRNA nuclear export factor complex” | binding |
| NXF2 | “form complex” | “NXF2-NXT2 mRNA nuclear export factor complex” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
27 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 21 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3218 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:102360646:C:CC | acceptor_gain | 1.0000 |
| X:102363261:A:AC | donor_gain | 1.0000 |
| X:102363262:C:CC | donor_gain | 1.0000 |
| X:102363441:ACAGA:A | acceptor_gain | 1.0000 |
| X:102363442:CAGA:C | acceptor_gain | 1.0000 |
| X:102363442:CAGAC:C | acceptor_gain | 1.0000 |
| X:102363443:AGA:A | acceptor_gain | 1.0000 |
| X:102363444:GA:G | acceptor_gain | 1.0000 |
| X:102363445:ACTGG:A | acceptor_loss | 1.0000 |
| X:102363446:C:CC | acceptor_gain | 1.0000 |
| X:102364053:C:CC | acceptor_gain | 1.0000 |
| X:102364786:CTCA:C | donor_loss | 1.0000 |
| X:102364787:TCA:T | donor_loss | 1.0000 |
| X:102364788:CACCG:C | donor_loss | 1.0000 |
| X:102364789:A:AC | donor_gain | 1.0000 |
| X:102364790:C:CC | donor_gain | 1.0000 |
| X:102364790:C:G | donor_loss | 1.0000 |
| X:102364790:CCGT:C | donor_gain | 1.0000 |
| X:102364902:CAGGT:C | acceptor_gain | 1.0000 |
| X:102364903:AGGT:A | acceptor_gain | 1.0000 |
| X:102364904:GGT:G | acceptor_gain | 1.0000 |
| X:102364905:GT:G | acceptor_gain | 1.0000 |
| X:102364907:C:CC | acceptor_gain | 1.0000 |
| X:102364907:C:CG | acceptor_loss | 1.0000 |
| X:102364909:G:C | acceptor_gain | 1.0000 |
| X:102365039:A:AC | donor_gain | 1.0000 |
| X:102365040:C:CC | donor_gain | 1.0000 |
| X:102365043:A:AC | donor_gain | 1.0000 |
| X:102365044:C:CC | donor_gain | 1.0000 |
| X:102365044:CAGGG:C | donor_gain | 1.0000 |
AlphaMissense
4189 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:102364018:G:C | F518L | 0.986 |
| X:102364018:G:T | F518L | 0.986 |
| X:102364020:A:G | F518L | 0.986 |
| X:102367810:G:C | N330K | 0.985 |
| X:102367810:G:T | N330K | 0.985 |
| X:102368061:A:C | N306K | 0.983 |
| X:102368061:A:T | N306K | 0.983 |
| X:102368155:A:G | L275S | 0.979 |
| X:102368071:A:G | L303P | 0.978 |
| X:102368062:T:A | N306I | 0.976 |
| X:102365471:G:C | F395L | 0.973 |
| X:102365471:G:T | F395L | 0.973 |
| X:102365473:A:G | F395L | 0.973 |
| X:102366064:A:C | L353W | 0.973 |
| X:102368071:A:T | L303H | 0.973 |
| X:102367826:A:G | L325P | 0.971 |
| X:102368063:T:G | N306H | 0.971 |
| X:102363284:A:G | M585T | 0.970 |
| X:102368149:A:G | L277S | 0.970 |
| X:102360804:G:C | F608L | 0.968 |
| X:102360804:G:T | F608L | 0.968 |
| X:102360806:A:G | F608L | 0.968 |
| X:102368554:A:G | L234P | 0.967 |
| X:102360833:A:G | W599R | 0.966 |
| X:102360833:A:T | W599R | 0.966 |
| X:102366064:A:G | L353S | 0.966 |
| X:102368560:A:T | L232H | 0.966 |
| X:102367820:A:G | L327P | 0.963 |
| X:102368062:T:G | N306T | 0.963 |
| X:102369055:A:C | F167L | 0.963 |
dbSNP variants (sampled 300 via entrez): RS10717019 (X:102374922 GA>G), RS1074809 (X:102416061 C>A), RS111565386 (X:102367395 T>C,G), RS111568334 (X:102433903 T>C), RS111593567 (X:102368703 G>GGT), RS111611048 (X:102389648 A>G), RS112512671 (X:102411025 A>C), RS112687938 (X:102397046 T>G), RS112804446 (X:102409913 C>T), RS112971909 (X:102380403 T>A), RS113034029 (X:102399361 C>T), RS113153946 (X:102439634 A>G), RS113264019 (X:102417092 A>T), RS113516503 (X:102432716 A>T), RS113641907 (X:102417396 G>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009391_130 | Metabolite levels | 2.000000e-06 |
| GCST009391_2052 | Metabolite levels | 2.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010355 | diacylglycerol 36:2 measurement |
| EFO:0010345 | cholesteryl ester 18:2 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases methylation | 1 |
| S-Nitrosoglutathione | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.